RECQL Gene Breast Cancer Susceptibility to Genetic Test sale cost 4400 AED
PTCH2 Gene Basal Cell Nevus Syndrome Due to Germline PTCH2 Mutation Genetic Test sale cost 4400 AED PTCH2 Gene Basal Cell Nevus Syndrome Due to Germline PTCH2 Mutation Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test sale cost 4400 AED MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

RECQL Gene Breast Cancer Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RECQL gene plays a significant role in DNA repair, and mutations within this gene have been associated with an increased susceptibility to breast cancer. Recognizing the importance of early detection and personalized medicine, DNA Labs UAE offers a genetic test specifically designed to identify mutations in the RECQL gene. This test is pivotal for individuals with a family history of breast cancer or those who are at a heightened risk due to genetic factors. By undergoing this test, patients can gain valuable insights into their genetic predisposition to breast cancer, enabling proactive health management and tailored preventive measures.

The cost of the RECQL gene breast cancer susceptibility genetic test at DNA Labs UAE is 4400 AED. The test is conducted using advanced genetic sequencing technologies to ensure accuracy and reliability. Results from this test can guide healthcare providers in recommending more precise screening schedules, preventive strategies, or even considering preventive treatments for those at increased risk. DNA Labs UAE ensures confidentiality and provides comprehensive support throughout the testing process, from pre-test counseling to post-test guidance based on the results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RECQL Gene Breast Cancer Susceptibility to Genetic Test

Test Name: RECQL Gene Breast Cancer Susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RECQL Gene Breast cancer, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RECQL Gene Breast cancer, susceptibility to NGS Genetic DNA Test gene RECQL

Test Details

The RECQL gene is involved in DNA repair and maintenance of genomic stability. Mutations in this gene have been associated with an increased risk of breast cancer.

NGS (Next-Generation Sequencing) genetic testing is a method that allows for the simultaneous analysis of multiple genes, including the RECQL gene, to identify any mutations or variants that may be present. This type of testing can provide valuable information about an individual’s genetic predisposition to certain diseases, including breast cancer.

By analyzing the RECQL gene using NGS technology, genetic testing can identify specific mutations or variants that may increase the risk of breast cancer. This information can help individuals and their healthcare providers make more informed decisions about screening, prevention, and treatment options.

It is important to note that a positive genetic test result does not mean that an individual will definitely develop breast cancer, but it does indicate an increased risk compared to the general population. Additionally, a negative test result does not completely rule out the possibility of developing breast cancer, as there may be other genetic and environmental factors at play.

If you are considering NGS genetic testing for breast cancer susceptibility, it is recommended to consult with a healthcare professional or genetic counselor who can provide guidance on the appropriateness and implications of testing for your specific situation. They can help you understand the potential benefits, limitations, and implications of the test results and assist in making informed decisions about your healthcare.

Test Name RECQL Gene Breast cancer susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RECQL Gene Breast cancer, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RECQL Gene Breast cancer, susceptibility to NGS Genetic DNA Test gene RECQL
Test Details

The RECQL gene is involved in DNA repair and maintenance of genomic stability. Mutations in this gene have been associated with an increased risk of breast cancer.

NGS (Next-Generation Sequencing) genetic testing is a method that allows for the simultaneous analysis of multiple genes, including the RECQL gene, to identify any mutations or variants that may be present. This type of testing can provide valuable information about an individual’s genetic predisposition to certain diseases, including breast cancer.

By analyzing the RECQL gene using NGS technology, genetic testing can identify specific mutations or variants that may increase the risk of breast cancer. This information can help individuals and their healthcare providers make more informed decisions about screening, prevention, and treatment options.

It is important to note that a positive genetic test result does not mean that an individual will definitely develop breast cancer, but it does indicate an increased risk compared to the general population. Additionally, a negative test result does not completely rule out the possibility of developing breast cancer, as there may be other genetic and environmental factors at play.

If you are considering NGS genetic testing for breast cancer susceptibility, it is recommended to consult with a healthcare professional or genetic counselor who can provide guidance on the appropriateness and implications of testing for your specific situation. They can help you understand the potential benefits, limitations, and implications of the test results and assist in making informed decisions about your healthcare.

SKU: TEST-4459 Category:

Related products